Association of Chronic Obstructive Pulmonary Disease Severity and Pneumocystis Colonization
Overview
Authors
Affiliations
Factors modulating the variable progression of chronic obstructive pulmonary disease (COPD) are largely unknown, but infectious agents may play a role. Because Pneumocystis has previously been shown to induce a CD8(+) lymphocyte- and neutrophil-predominant response similar to that in COPD, we explored the association of the organism with accelerated disease progression. We examined Pneumocystis colonization rates in lung tissue obtained during lung resection or transplantation in smokers with a range of airway obstruction severity and in a control group with lung diseases other than COPD. Using nested polymerase chain reaction, Pneumocystis colonization was detected in 36.7% of patients with very severe COPD (Global Health Initiative on Obstructive Lung Disease [GOLD] Stage IV) compared with 5.3% of smokers with normal lung function or less severe COPD (Stages 0, I, II, and III) (p = 0.004) and with 9.1% of control subjects (p = 0.007). Colonized subjects exhibited more severe airway obstruction (median FEV(1) = 21% predicted versus 62% in noncolonized subjects, p = 0.006). GOLD IV was the strongest predictor of Pneumocystis colonization (odds ratio = 7.3, 95% confidence interval = 2.4-22.4, p < 0.001) and was independent of smoking history. We conclude that there is a strong association between Pneumocystis colonization and severity of airflow obstruction in smokers, suggesting a possible pathogenic link with COPD progression.
The lung proteome in HIV-associated obstructive lung disease.
Samorodnitsky S, Weise D, Lock E, Kunisaki K, Morris A, Leung J ERJ Open Res. 2025; 11(2).
PMID: 40040889 PMC: 11874292. DOI: 10.1183/23120541.00204-2024.
The airway mycobiome and interactions with immunity in health and chronic lung disease.
Katsoulis O, Pitts O, Singanayagam A Oxf Open Immunol. 2024; 5(1):iqae009.
PMID: 39206335 PMC: 11357796. DOI: 10.1093/oxfimm/iqae009.
Coronado K, Herrada C, Rojas D Int J Mol Sci. 2024; 25(6).
PMID: 38542124 PMC: 10969872. DOI: 10.3390/ijms25063150.
Trends in the Epidemiology of Pneumonia in Immunocompromised Patients without HIV Infection.
Xue T, Kong X, Ma L J Fungi (Basel). 2023; 9(8).
PMID: 37623583 PMC: 10455156. DOI: 10.3390/jof9080812.
Exacerbates Inflammation and Mucus Hypersecretion in a Murine, Elastase-Induced-COPD Model.
Rojas D, Ponce C, Bustos A, Cortes V, Olivares D, Vargas S J Fungi (Basel). 2023; 9(4).
PMID: 37108906 PMC: 10142929. DOI: 10.3390/jof9040452.